TG Therapeutics, Inc. (NKB2)
Market Closed
3 Jun, 20:00
XSTU 
€
34. 50
+3.1
+9.87%
€
- Market Cap
- P/E Ratio
- Div Yield
400 Volume
0.03 Eps
€ 31.4
Previous Close Want to track NKB2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.3 | - |
| | | 0.33 | - |
| | | 0.21 | - |
| | | 0.29 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NKB2 Earnings Reports FAQ
What is the earnings per share (EPS) for NKB2?
The current EPS is 0.03.
What is the company's earnings growth rate?
TG Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
TG Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for TG Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NKB2 at this time, as TG Therapeutics, Inc has no recent EPS data to calculate it.
